Cargando…

S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA

BACKGROUND: Schizophrenia (Sz) and other psychoses are complex mental disorders, characterised by sensory, cognitive and emotional symptoms, but mainly distinguished by positive and negative symptoms. Cognitive impairment is a core feature of schizophrenia, with research into cognitive deficits indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millgate, Edward, Kravariti, Eugenia, MacCabe, James, Hide, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234049/ http://dx.doi.org/10.1093/schbul/sbaa031.128

Ejemplares similares

Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
por: Millgate, Edward, et al.
Publicado: (2022)

M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020)

S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY
por: Spangaro, Marco, et al.
Publicado: (2020)

S66. USING UNITIZATION TO CIRCUMVENT RELATIONAL MEMORY DEFICITS IN SCHIZOPHRENIA
por: de Sousa, Ana Elisa Farias, et al.
Publicado: (2020)

T19. GLUTAMATE AND RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Egerton, Alice, et al.
Publicado: (2020)

T62. A COMPUTATIONAL ANALYSIS OF MOTIVATIONAL DEFICITS IN SCHIZOPHRENIA SPECTRUM DISORDERS
por: Waltz, James, et al.
Publicado: (2020)

S58. COMPARISON OF FACE EMOTIONAL RECOGNITION DEFICITS IN REMITTED SCHIZOPHRENIA AND BIPOLAR I DISORDER
por: Won, Seunghee, et al.
Publicado: (2020)

S194. CLOZAPINE AND ELECTROCONVULSIVE THERAPY AUGMENTATION IN ADOLESCENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA
por: Jeong Park, Kee, et al.
Publicado: (2020)

S15. BIMODAL DISTRIBUTION OF TONE-MATCHING DEFICITS INDICATES DISCRETE PATHOPHYSIOLOGICAL ENTITIES WITHIN THE SYNDROME OF SCHIZOPHRENIA
Publicado: (2020)

S237. MODERATORS AND RELATIONSHIPS OF COGNITION AND SUBJECTIVE QUALITY OF LIFE IN SCHIZOPHRENIA
por: Tan, Eric, et al.
Publicado: (2020)

S170. PROGRESSIVE SUBCORTICAL VOLUME LOSS IN TREATMENT-RESISTANT SCHIZOPHRENIA PATIENTS AFTER COMMENCING CLOZAPINE TREATMENT
por: Tronchin, Giulia, et al.
Publicado: (2020)

S50. COGNITION AND EMOTION REGULATION IN SCHIZOPHRENIA PATIENTS WITH A HISTORY OF AGGRESSION
por: Ahmed, Anthony, et al.
Publicado: (2020)

S207. CHRONIC TREATMENT WITH 1METIQ INDUCES PRO-COGNITIVE EFFECT ON RECOGNITION MEMORY IN KETAMINE MODEL OF SCHIZOPHRENIA IN RATS
por: Białoń, Magdalena, et al.
Publicado: (2020)

S202. PROXIMAL AND DISTAL FACTORS ASSOCIATED WITH CLOZAPINE EXPOSURE IN A SAMPLE OF TREATMENT RESISTANT AND TREATMENT RESPONSIVE SCHIZOPHRENIA PATIENTS
por: Barone, Annarita, et al.
Publicado: (2020)

S56. SWITCHING FROM RISPERIDONE TO PALIPERIDONE PALMITATE IN SCHIZOPHRENIA: CHANGES IN COGNITIVE FUNCTION
por: Tost Bonet, Meritxell, et al.
Publicado: (2020)

S105. DIGITAL BIOMARKERS FOR THE ASSESSMENT OF COGNITIVE, BEHAVIORAL AND FUNCTIONAL OUTCOMES IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Lindenmayer, Jean-Pierre, et al.
Publicado: (2020)

S235. COGNITION AND SOCIAL BEHAVIORS IN SPORTS FOR PATIENTS WITH SCHIZOPHRENIA ENGAGED IN SPORTS HABITS
por: Yoshihara, Yujiro, et al.
Publicado: (2020)

S84. EFFECTS OF COGNITIVE REHABILITATION AND ILLNESS DURATION ON VERBAL MEMORY AND LEARNING IN SCHIZOPHRENIA
por: Kontis, Dimitrios, et al.
Publicado: (2020)

S52. SPATIAL MEMORY DEFICITS IN SCHIZOPHRENIA: NEUROLOGICAL SOFT SIGNS DIFFERENTIALLY INFLUENCE PERFORMANCES IN 3-D VIRTUAL VERSUS TACTILE RECOGNITION TASKS
por: Abichou, Kouloud, et al.
Publicado: (2020)

S180. THE SELECTIVE GPR139 AGONIST TAK-041 REVERSES ANHEDONIA AND SOCIAL INTERACTION DEFICITS IN RODENT MODELS RELATED TO NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
por: Schiffer, Hans, et al.
Publicado: (2020)

S125. THE ROLE OF DUP, DUI AND POLYGENIC SCORE FOR SCHIZOPHRENIA ON COGNITION IN ATHENS FEP STUDY SAMPLE
por: Dimitrakopoulos, Stefanos, et al.
Publicado: (2020)

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
por: Millgate, Edward, et al.
Publicado: (2021)

S57. CHARACTERIZING COGNITIVE HETEROGENEITY IN INDIVIDUALS WITH A SCHIZOPHRENIA SPECTRUM DISORDER: A CLUSTER ANALYTIC APPROACH
por: Brand, Bodyl
Publicado: (2020)

S176. A PRELIMINARY INVESTIGATION OF COMT GENE INVOLVEMENT IN COGNITIVE FLEXIBILITY AND ATTENTION IN SCHIZOPHRENIA SPECTRUM DISORDERS
por: Morris, Kim, et al.
Publicado: (2020)

S48. INSIGHT VS COGNITION AND SYMPTOMATIC REMISSION AMONG PATIENTS WITH SCHIZOPHRENIA- THE INFLUENCE OF TRAIT VS STATE PHENOMENON?
por: Helldin, Lars, et al.
Publicado: (2020)

S72. MCCB COGNITIVE PROFILE IN CHINESE FIRST EPISODE SCHIZOPHRENIA PATIENTS AND SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Lei, Zhao, et al.
Publicado: (2020)

S63. CLINICAL AND DEVELOPMENTAL CHARACTERISTICS OF COGNITIVE SUBGROUPS IN A TRANSDIAGNOSTIC SAMPLE OF SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER AND BIPOLAR DISORDER
por: Bora, Emre, et al.
Publicado: (2020)

S54. THE RELATION OF FORMAL THOUGHT DISORDER WITH COGNITIVE FUNCTIONS, GLOBAL AND SOCIAL FUNCTIONING AND QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA
por: Mutlu, Emre, et al.
Publicado: (2020)

S68. DIFFERENTIAL PATTERN OF SOCIAL COGNITION IMPAIRMENT BETWEEN RURAL AND URBAN DWELLING PATIENTS OF SCHIZOPHRENIA AND ITS FUNCTIONAL CORRELATES
por: Ibrahim, Ferose, et al.
Publicado: (2020)

S74. AEROBIC EXERCISE AND COGNITIVE REMEDIATION IN MULTIEPISODE SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER: PRELIMINARY RESULTS: FROM A RANDOMIZED CLINICAL TRIAL
por: Pujol, Nuria, et al.
Publicado: (2020)

S156. PUBLIC ATTENTION TO CRIME OF SCHIZOPHRENIA AND ITS CORRELATION WITH USE OF MENTAL HEALTH SERVICES IN PATIENTS WITH SCHIZOPHRENIA
por: Park, Hyunwoo, et al.
Publicado: (2020)

S146. ASSOCIATION OF IMPAIRED MODEL-FREE DECISION-MAKING WITH ABERRANT STRIATAL DOPAMINE, BRAIN ACTIVATION, AND COGNITIVE DIFFICULTIES IN PATIENTS WITH SCHIZOPHRENIA DURING PSYCHOTIC REMISSION
por: Brandl, Felix, et al.
Publicado: (2020)

S40. COMBINING PHARMACOTHERAPY OF BI 425809 WITH COMPUTERISED COGNITIVE TRAINING IN PATIENTS WITH SCHIZOPHRENIA: INITIAL EXPERIENCE OF A LARGE-SCALE MULTICENTRE RANDOMISED CLINICAL TRIAL
por: Hake, Sanjay, et al.
Publicado: (2020)

S91. OPIOID USE AND SCHIZOPHRENIA: AN UPDATE
Publicado: (2020)

S140. CHARACTERISTICS OF COGNITIVE CONTROL SPECIALIZATION IN HEALTHY AND PATIENT POPULATIONS
por: Kwashie, Anita, et al.
Publicado: (2020)

S200. COMPARISON BETWEEN LONG-ACTING INJECTABLE ARIPIPRAZOLE VERSUS PALIPERIDONE PALMITATE IN THE TREATMENT OF SCHIZOPHRENIA: SYSTEMATIC REVIEW AND INDIRECT TREATMENT COMPARISON
Publicado: (2020)

S198. SELF-DISTURBANCES AND THEIR NEURAL SIGNATURES IN SCHIZOPHRENIA
por: Zaytseva, Yulia, et al.
Publicado: (2020)

S155. DIETARY PATTERNS AND OBESITY IN INDIVIDUALS WITH SCHIZOPHRENIA
por: Amirah Abdul Rashid, Nur, et al.
Publicado: (2020)

S142. NOVEL CONCEPTS OF SOCIAL IMPAIRMENTS IN SCHIZOPHRENIA
por: Bitsch, Florian, et al.
Publicado: (2020)

S158. URBANICITY INDEX AND CORTICAL GYRIFICATION IN SCHIZOPHRENIA
por: Korann, Vittal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b75im3nluqn82q592qvja8avc2